Dallas, TX: April, 18th 2016
Dallas based Bone Solutions, Inc. signs distribution
agreement with Next Health Bone Solutions of Dallas, TX has signed an exclusive
distribution agreement for a ten state geography with Next Health, a Dallas based
orthopedic distribution company. Bone Solutions Inc., is positioned to launch its
FDA approved OsteoCrete magnesium technology this summer for the domestic and international
extremities markets. Drew Diaz, Bone Solution’s CEO, stated “We are extremely pleased
to be positioned with Next Health for the launch of our much awaited magnesium based
technology. OsteoCrete will be the first product in the marketplace utilizing magnesium
for its Orthobiologic platform”.
Next Health is a Dallas based orthopedic distributor
with a strong foot print in multiple states throughout the United States. This new partnership will bring both the strength
of a strong distribution model along with an exciting and disruptive technology
in the Orthobiologic marketplace. Kent Sohosky, Next Health President, “We are very
excited to be partnering with such an innovative company as Bone Solutions. Next Health looks forward to driving the
market adoption of OsteoCrete throughout the United Sates”.
BSI will begin the FDA process for the Spinal, Dental
and Craniomaxillofacial markets once OsteoCrete is launched in the general
orthopedic and extremities market this year. The company believes this technology
can open the door for many new applications and techniques in the orthopedic market,
creating potential new large markets for Bone Solutions Inc. products.
The company also noted that to date, a surge in biomaterials
capable of treating orthopedic injuries has led to a Multitude of products such
as bone cements to attach various objects to bone, and bone void fillers capable
of treating bone fractures and other bone defects.
Contact:
Drew Diaz
President/CEO
817680968850
No comments:
Post a Comment